Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 3997.00 | 3812.75 | 1.0483 | 1.0681 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4272.00 | 3812.75 | 1.1205 | 1.1680 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 1898.00 | 3812.75 | 0.4978 | 0.2194 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 3787.00 | 3812.75 | 0.9933 | 0.9904 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 3415.00 | 3812.75 | 0.8957 | 0.8497 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 4121.00 | 3812.75 | 1.0808 | 1.1134 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 2500.00 | 1434.95 | 3901.00 | 3812.75 | 1.0231 | 1.0327 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1434.95 | 3480.00 | 3812.75 | 0.9127 | 0.8746 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 3804.00 | 3812.75 | 0.9977 | 0.9967 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 3772.00 | 3812.75 | 0.9893 | 0.9848 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1434.95 | 1340.00 | 3812.75 | 0.3515 | -0.0474 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 3918.00 | 3812.75 | 1.0276 | 1.0390 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3666.00 | 3812.75 | 0.9615 | 0.9451 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 3836.00 | 3812.75 | 1.0061 | 1.0086 |
| BT-20 | Lapatinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3352.00 | 3812.75 | 0.8792 | 0.8254 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3657.00 | 3812.75 | 0.9592 | 0.9417 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7030.00 | 7049.00 | 0.9973 | 0.9959 | |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 6881.00 | 7049.00 | 0.9762 | 0.9640 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 5143.00 | 7049.00 | 0.7296 | 0.5772 |
| BT-20 | Linsitinib | 10 | uM | 9 | 5000.00 | 2808.68 | 6039.00 | 7049.00 | 0.8567 | 0.7801 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 6613.00 | 7049.00 | 0.9382 | 0.9061 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 3240.00 | 7049.00 | 0.4596 | 0.1136 |
| BT-20 | Erlotinib | 1 | uM | 9 | 5000.00 | 2808.68 | 5178.00 | 7049.00 | 0.7346 | 0.5853 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 2808.68 | 6866.00 | 7049.00 | 0.9740 | 0.9608 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7104.00 | 7049.00 | 1.0078 | 1.0117 |